Welcome to the
Hepatitis B Foundation
Starved T Cells Allow Hepatitis B to Silently Infect Liver
May 18 – Hepatitis B stimulates processes that deprive the body's immune cells of key nutrients that they need to function, finds new UCL-led research funded by the Medical Research Council and Wellcome Trust. Read more.
Nucleic Acid Polymer REP 2139-Ca Shows Promise Against Hepatitis B and Delta Viruses
May 18 – The nucleic acid-based polymer REP 2139-Ca lowered hepatitis B surface antigen levels and significantly reduced hepatitis B and hepatitis delta viral loads when combined with immunotherapy, according to presentations at the European Association for the Study of the Liver (EASL) 50th International Liver Congress last month in Vienna. Read more.
Sequencing Technique Unveiling the Realm of Viral Mutations
May 18 – Researchers at A*STAR have devised a sequencing technique that can track specific viral variants produced when viruses such as hepatitis B rapidly mutate within individual patients. The breakthrough allows an unprecedented view of evolving virus population structures, and could help in the creation of new drugs that prevent the development of strains resistant to drugs and immune responses. Read more.
MD Anderson Researchers Find Significant Clinical Variations Among Liver Cancer Patients
May 18 – Significant clinical variations exist among patients with hepatocellular carcinoma, depending on the viral cause of the disease -hepatitis B virus or hepatitis C virus. These differences suggest that hepatitis status should be considered when developing treatment plans for newly diagnosed patients, according to researchers at The University of Texas MD Anderson Cancer Center. Read more.
Pennsylvania Legislature Recognizes Hepatitis Awareness Month
May 11 - The great State of Pennsylvania, home to the Hepatitis B Foundation and the Baruch S. Blumburg Institute, recognizes Hepatitis Awareness Month and May 19th as Hepatitis Testing Day. View the PECO lights for an important message for the City of Philadelphia! View now.
HBF’s Baruch S. Blumberg Institute Partners with University of Pennsylvania for Masters of Chemical Sciences Program
May 1 – The Baruch S. Blumberg Institute, the research arm of the HBF, has finalized an agreement that allows University of Pennsylvania chemistry graduate students to complete their research at the Institute. This will bring high-caliber research support to the Blumberg Institute, while providing real-world research experience to the students. Read more.
Dr. Eugene Schiff Receives Hepatitis B Foundation’s Highest Scientific Honor
April 20 – The 2015 Crystal Ball Gala, hosted by the Hepatitis B Foundation, was a huge success, and included an evening of dinner, dancing, live and silent auctions, a mission moment, and the awarding of the Baruch S. Blumberg Prize to Dr. Eugene Schiff for advancing the care and treatment of chronic hepatitis B. Read more.
Institute Assembles Team of 'All-Star Researchers' to Cure Hepatitis B
April 6– The Baruch S. Blumberg Institute has recruited a new team of nationally renowned, “all Star researchers” who will focus exclusively on developing a cure for hepatitis B, with a goal for breakthrough therapies within the next three years. Read more.
Page last modified May 11, 2015